The author replies

New England Journal of Medicine

Volumn 368, Issue 21, 2013, Pages 2041-2042

  Stabler, Sally P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANIDE; CYANOCOBALAMIN; HYDROXOCOBALAMIN; MECOBALAMIN;

CYANOCOBALAMIN DEFICIENCY; DRUG MEGADOSE; HEMODIALYSIS; HUMAN; LETTER; MEGALOBLASTIC ANEMIA; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SMOKING; SPINAL CORD DISEASE; FEMALE; NOTE;

FEMALE; HUMANS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84877978315     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1304350     Document Type: Article

References (4)

1. Environmental Protection Agency. Integrated Risk Information System (IRIS) home page (http://www.epa.gov.iris).
2. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-8.
3. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Baructa S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther 2003;25:3124-34.
4. Nilsson M, Norberg B, Hultdin J, et al. Medical intelligence in Sweden; vitamin B12: oral compared with parenteral? Postgrad Med J 2005;81:191-3.